Target intelligence / Profile preview

ATPase phospholipid transporting 8A2 pseudogene 2 (ATP8A2P2)

Target
ATP8A2P2
Molecular classification
Other (Pseudogene)
01

Overview

ATP8A2P2 is a processed pseudogene related to the ATP8A2 gene, which encodes a P4-ATPase (“aminophospholipid translocase”) involved in phospholipid transport across membranes. Unlike its parent gene, ATP8A2P2 does not encode a functional protein. Pseudogenes generally arise from gene duplication or retrotransposition followed by the accumulation of disabling mutations, such as premature stop codons or frameshifts. While some pseudogenes regulate their parental genes through transcript-based mechanisms (e.g., as siRNAs or miRNA sponges), no evidence links ATP8A2P2 to such regulatory functions or disease relevance. It should not be considered a therapeutic target, and its inclusion in lists of drug targets or gene function databases is for informational or annotation purposes only. There is nothing to suggest ATP8A2P2 itself serves as a receptor, enzyme, transporter, or a therapeutic target of any kind. If ATP8A2P2 was referenced as a drug target, that would be an error.

Other names
ATP8A2P2ATPase, aminophospholipid transporter, class I, type 8A, member 2 pseudogene 2
02

Mechanism of action

Not applicable. As a pseudogene, ATP8A2P2 produces no protein product and has no known direct pharmacological mechanism.

03

Biological functions

Most pseudogenes, including ATP8A2P2, do not encode functional proteins but may participate in gene regulation (e.g., as noncoding RNA or miRNA decoys in rare cases)Some pseudogenes can influence expression of related genes via regulatory mechanisms, such as acting as competing endogenous RNAs (ceRNAs) or generating noncoding RNAs that affect gene silencing. However, there is no evidence for such a functional role for ATP8A2P2 itself.
04

Disease associations

None known specifically for ATP8A2P2. No established link to disease.
05

Safety considerations

None relevant, as it is not a drug target.
06

Interacting drugs

None.
07

Biomarkers

None established.

Beyond the preview

Go deeper on ATPase phospholipid transporting 8A2 pseudogene 2 (ATP8A2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATPase phospholipid transporting 8A2 pseudogene 2 (ATP8A2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call